MAYNE PHARMA GROUP LIMITED

INVESTOR PRESENTATION - MAYNE PHARMA GROUP LIMITED

ASX:MYX

MAYNE PHARMA GROUP LIMITED

Health Care

Mayne Pharma Group Limited (MYX) is a pharmaceutical company that develops and manufactures branded and generic products, which it distributes directly or through distribution partners in Australia, USA, Europe and Asia. Mayne Pharma has two drug development and manufacturing facilities based in Salisbury, Australia and Greenville, NC, USA. Former Names Halcygen Pharmaceuticals Limited (HGN), 18/11/2010

Market Cap

596.07m

Price at Close

$0.355

4w avg. Volume

3.21m

4w avg. Turnover

$1.27m

Announcements
announcementt+2 movementdate
  • Change in substantial holding

    Shareholder Details

  • +1.16%

    07 Jul 2020

+1.16%

07 Jul 2020
  • Mayne Pharma announces strategic partnership with Novast

    Progress Report · Market sensitive

  • +4.71%

    05 Jul 2020

+4.71%

05 Jul 2020
  • MYX announces FDA filing acceptance of E4/DRSP in the US

    Progress Report · Market sensitive

  • -1.35%

    23 Jun 2020

-1.35%

23 Jun 2020
  • Lapse of unlisted employee performance rights

    Issued Capital

  • -2.67%

    15 Jun 2020

-2.67%

15 Jun 2020
  • S&P DJI Announces June 2020 Quarterly Rebalance

    Other · Market sensitive

  • -14.77%

    11 Jun 2020

-14.77%

11 Jun 2020
  • Becoming a substantial holder

    Shareholder Details

  • +4.49%

    03 Jun 2020

+4.49%

03 Jun 2020
  • Ceasing to be a substantial holder

    Shareholder Details

  • +4.71%

    01 Jun 2020

+4.71%

01 Jun 2020
  • MYX signs license agreement for contraceptive in Australia

    Progress Report · Market sensitive

  • -2.30%

    28 May 2020

-2.30%

28 May 2020
  • Becoming a substantial holder

    Shareholder Details

  • -1.11%

    25 May 2020

-1.11%

25 May 2020
  • Mayne Pharma submits NDA for E4/DRSP to the FDA

    Progress Report · Market sensitive

  • +14.49%

    15 Apr 2020

+14.49%

15 Apr 2020
Market Data

Current Price

$0.355

52WK HIGH

$0.645

52WK LOW

$0.195

1YR RETURN

-26.80%

1YR RETURN VS. SECTOR

-48.93%

90 DAY RETURN

-16.47%

ASX RANK

321

/2,032

SECTOR RANK

1

/32

SHARES OUTSTANDING

1.68b
ASX:MYX

MAYNE PHARMA GROUP LIMITED

Health Care

Mayne Pharma Group Limited (MYX) is a pharmaceutical company that develops and manufactures branded and generic products, which it distributes directly or through distribution partners in Australia, USA, Europe and Asia. Mayne Pharma has two drug development and manufacturing facilities based in Salisbury, Australia and Greenville, NC, USA. Former Names Halcygen Pharmaceuticals Limited (HGN), 18/11/2010

Market Cap

596.07m

Price at Close

$0.355

4w avg. Volume

3.21m

4w avg. Turnover

$1.27m

ASX:MYX is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Support

Ask Fresh

Archive
Contact Us

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

(03) 9028 2888

deals@freshequities.com

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.